Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PharmaEssentia Corporation (TWO: 6446)

 
6446 Technical Analysis
1.5
As on 9th Jun 2023 6446 STOCK Price closed @ 336.50 and we RECOMMEND Sell for LONG-TERM with Stoploss of 408.26 & Buy for SHORT-TERM with Stoploss of 284.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6446STOCK Price

Open 337.50 Change Price %
High 339.00 1 Day -1.00 -0.30
Low 333.00 1 Week -13.50 -3.86
Close 336.50 1 Month -26.00 -7.17
Volume 2179179 1 Year 96.50 40.21
52 Week High 619.00 | 52 Week Low 236.50
 
TWO Taiwan Most Active Stocks
6125 44.70 5.67%
4533 18.00 9.76%
4979 76.40 9.93%
6122 44.45 9.89%
5425 102.00 9.09%
8358 63.30 4.11%
3374 128.00 9.87%
2743 162.50 -7.93%
8069 227.00 5.09%
1815 13.95 6.08%
 
TWO Taiwan Top Gainers Stocks
5465 46.20 10.00%
4979 76.40 9.93%
8234 52.60 9.93%
5703 37.65 9.93%
5703 37.65 9.93%
4543 57.60 9.92%
3078 72.00 9.92%
6122 44.45 9.89%
6122 44.45 9.89%
6148 38.40 9.87%
 
TWO Taiwan Top Losers Stocks
6174 27.70 -10.65%
1796 114.00 -9.88%
1796 114.00 -9.88%
2743 162.50 -7.93%
2736 44.35 -7.60%
3631 31.65 -5.52%
1580 124.50 -5.32%
1580 124.50 -5.32%
3522 18.35 -4.92%
3252 25.20 -4.73%
 
 
6446
Daily Charts		 6446
Intraday Charts		 Whats New @
Bazaartrend		 6446
Free Analysis
 
6446 Important Levels Intraday
RESISTANCE348.06
RESISTANCE344.35
RESISTANCE342.06
RESISTANCE339.77
SUPPORT333.23
SUPPORT330.94
SUPPORT328.65
SUPPORT324.94
 
6446 Forecast May 2024
Share
4th UP Forecast479.1
3rd UP Forecast433.37
2nd UP Forecast405.1
1st UP Forecast376.83
1st DOWN Forecast296.17
2nd DOWN Forecast267.9
3rd DOWN Forecast239.63
4th DOWN Forecast193.9
 
6446 Weekly Forecast
4th UP Forecast611.10
3rd UP Forecast523.03
2nd UP Forecast468.60
1st UP Forecast414.16
1st DOWN Forecast258.84
2nd DOWN Forecast204.40
3rd DOWN Forecast149.97
4th DOWN Forecast61.90
 
6446 Forecast2024
4th UP Forecast1084.18
3rd UP Forecast844.39
2nd UP Forecast696.18
1st UP Forecast547.96
1st DOWN Forecast125.04
2nd DOWN Forecast-23.18
3rd DOWN Forecast-171.39
4th DOWN Forecast-411.18
 
 
6446 Other Details
Segment EQ
Market Capital 25268811776.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
6446 Address
6446
 
6446 Latest News
 
Your Comments and Response on PharmaEssentia Corporation
 
6446 Business Profile
PharmaEssentia Corporation engages in the research, development, production, and sale of therapeutic products for the treatment of human diseases. Its products include ropeginterferon alfa-2b that is used for the treatment of polycythemia vera, essential thrombocythemia, and hepatitis B and C; and Anti-PD-1 antibody for the treatment of cancer. The company also licensed to develop Oraxol for the treatment of breast, advanced gastric, and esophageal cancer; KX01 for the treatment of psoriasis and actinic keratosis. It also focuses on the drug research and development programs in the areas of hematology, infectious disease, oncology, and dermatology. The company has a research collaboration agreement with Axis Therapeutics Limite for the development of T Cell Receptor-T therapy based on the T cell receptor affinity enhancing specific T cell therapy technology platform. PharmaEssentia Corporation was founded in 2003 and is headquartered in Taipei, Taiwan. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service